Ben-Yosef Noam, Frampton Matthew, Schiff Elena R, Daher Saleh, Abu Baker Fadi, Safadi Rifaat, Israeli Eran, Segal Anthony W, Levine Adam P
Centre for Molecular Medicine, Division of Medicine, University College London, London, UK.
Institute of Gastroenterology and Liver disease, Hadassah Medical Center, Jerusalem, Israel.
Gastroenterol Rep (Oxf). 2021 Jul 13;9(6):521-532. doi: 10.1093/gastro/goab007. eCollection 2021 Dec.
Family studies support a genetic predisposition to inflammatory bowel diseases (IBD), but known genetic variants only partially explain the disease heritability. Families with multiple affected individuals potentially harbour rare and high-impact causal variants. Long regions of homozygosity due to recent inbreeding may increase the risk of individuals bearing homozygous loss-of-function variants. This study aimed to identify rare and homozygous genetic variants contributing to IBD.
Four families with known consanguinity and multiple cases of IBD were recruited. In a family-specific analysis, we utilised homozygosity mapping complemented by whole-exome sequencing.
We detected a single region of homozygosity shared by Crohn's disease cases from a family of Druze ancestry, spanning 2.6 Mb containing the gene. Whole-exome sequencing did not identify any potentially damaging variants within the region, suggesting that non-coding variation may be involved. In addition, affected individuals in the families harboured several rare and potentially damaging homozygous variants in genes with a role in autophagy and innate immunity including , , , and .
This study examined the potential contribution of rare, high-impact homozygous variants in consanguineous families with IBD. While the analysis was not designed to achieve statistical significance, our findings highlight genes or loci that warrant further research. Non-coding variants affecting may be of importance in Druze patients with Crohn's disease.
家族研究支持炎症性肠病(IBD)存在遗传易感性,但已知的基因变异仅部分解释了该疾病的遗传力。有多个患病个体的家族可能携带着罕见且具有高影响力的致病变异。由于近期近亲繁殖导致的长纯合区域可能会增加携带纯合功能丧失变异个体的风险。本研究旨在鉴定导致IBD的罕见和纯合基因变异。
招募了四个有已知近亲关系且有多个IBD病例的家族。在家族特异性分析中,我们利用纯合性定位并辅以全外显子测序。
我们在一个德鲁兹血统家族的克罗恩病病例中检测到一个共享的单一纯合区域,跨度为2.6兆碱基,包含 基因。全外显子测序未在该区域内鉴定出任何潜在有害变异,提示可能涉及非编码变异。此外,这些家族中的患病个体在参与自噬和先天免疫的基因中携带了几个罕见且可能有害的纯合变异,包括 、 、 和 。
本研究探讨了IBD近亲家族中罕见、高影响力纯合变异的潜在贡献。虽然该分析并非旨在达到统计学显著性,但我们的发现突出了值得进一步研究的基因或基因座。影响 的非编码变异在患有克罗恩病的德鲁兹患者中可能具有重要意义。